Literature DB >> 8269560

Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury.

T Kawamura1, R Wakusawa, K Okada, S Inada.   

Abstract

Myocardial ischaemia is one of the major causes of low output syndrome during open heart surgery. Injury associated with ischaemia and reperfusion has been considered to result, in part, from the action of neutrophils, the interaction of neutrophils with vascular endothelial cells, and the effects of cytokines which are mediators that induce and modify reactions between these substances. We investigated cell injury in relation to the concentrations of interleukins 6 and 8 (IL-6 and IL-8), which have recently received attention as neutrophil activators. Neutrophil counts, granulocyte elastase (GEL), IL-6, IL-8, tumour necrosis factor-alpha (TNF-alpha), CK, and CK-MB concentrations were determined serially in 11 patients undergoing open heart surgery with cardiopulmonary bypass (CPB). Neutrophil counts (mean +/- SD 2717 +/- 2421 microliters-1 preoperatively) peaked 60 min after declamping the aorta at 7432 +/- 4357 microliters-1 (P < 0.01) and remained elevated 7136 +/- 5194 microliters-1 at 180 min (P < 0.01). Plasma GEL level (168 +/- 71 micrograms.L-1 preoperatively) peaked at 1134 +/- 453 micrograms.L-1 120 min after declamping of the aorta (P < 0.01) and remained elevated, 1062 +/- 467 micrograms.L-1, after 180 min (P < 0.01). Serum IL-6 level (118 +/- 59 pg.ml-1 preoperatively) peaked at 436 +/- 143 pg.ml-1 60 min after declamping of the aorta (P < 0.01) and remained elevated, 332 +/- 109 pg.ml-1, after 180 min. Serum IL-8 level (37 +/- 44 pg.ml-1 preoperatively) peaked at 169 +/- 86 pg.ml-1 at 60 min after declamping of the aorta (P < 0.001) and remained elevated at 113 +/- 78 pg.ml-1 180 min after declamping of the aorta.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8269560     DOI: 10.1007/bf03009470

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  20 in total

1.  Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.

Authors:  J M Schröder; U Mrowietz; E Morita; E Christophers
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

2.  NAP-1/IL-8 induces up-regulation of CR1 receptors in human neutrophil leukocytes.

Authors:  J P Paccaud; J A Schifferli; M Baggiolini
Journal:  Biochem Biophys Res Commun       Date:  1990-01-15       Impact factor: 3.575

3.  Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor.

Authors:  C G Larsen; A O Anderson; J J Oppenheim; K Matsushima
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

4.  Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins.

Authors:  M B Lawrence; T A Springer
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

5.  Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs.

Authors:  K M Mullane; N Read; J A Salmon; S Moncada
Journal:  J Pharmacol Exp Ther       Date:  1984-02       Impact factor: 4.030

6.  A highly sensitive enzyme-linked immunosorbent assay for the measurement of interleukin-8 in biological fluids.

Authors:  N Ida; S Sakurai; K Hosoi; T Kunitomo
Journal:  J Immunol Methods       Date:  1992-11-25       Impact factor: 2.303

7.  Neutrophil-mediated solubilization of the subendothelial matrix: oxidative and nonoxidative mechanisms of proteolysis used by normal and chronic granulomatous disease phagocytes.

Authors:  S J Weiss; J T Curnutte; S Regiani
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

8.  The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate.

Authors:  J M Schröder
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

9.  Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils.

Authors:  P A Detmers; S K Lo; E Olsen-Egbert; A Walz; M Baggiolini; Z A Cohn
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

10.  A novel neutrophil-activating factor produced by human mononuclear phagocytes.

Authors:  P Peveri; A Walz; B Dewald; M Baggiolini
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

View more
  28 in total

1.  Continuous renal replacement therapy with a polymethyl methacrylate membrane hemofilter suppresses inflammation in patients after open-heart surgery with cardiopulmonary bypass.

Authors:  Hiroshi Mukaida; Satoshi Matsushita; Takahiro Inotani; Atsushi Nakamura; Atsushi Amano
Journal:  J Artif Organs       Date:  2018-02-05       Impact factor: 1.731

2.  Ulinastatin reduces elevation of cytokines and soluble adhesion molecules during cardiac surgery.

Authors:  T Kawamura; K Inada; N Akasaka; R Wakusawa
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

3.  Predictive value of interleukin 6 (IL-6), interleukin 8 (IL-8) and gastric intramucosal pH (pH-i) in major abdominal surgery.

Authors:  A Donati; D Battisti; A Recchioni; P Paoletti; G Conti; S Caporelli; E Adrario; P Pelaia; P Pietropaoli
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

4.  Perioperative serum levels of tumour-necrosis-factor alpha (TNF-alpha), IL-1 beta, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution.

Authors:  A Roth-Isigkeit; T V Borstel; M Seyfarth; P Schmucker
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

5.  Eotaxin-2 induces monocytic apoptosis in patients who have undergone coronary artery bypass surgery and in THP-1 cells in vitro regulated by thrombomodulin.

Authors:  Yi-Wen Lin; Chun-Yao Huang; Chun-Min Shih; Yi-Ting Tsai; Chin-Sheng Lin; Chih-Yuan Lin; Chi-Yuan Li; Shih-Hurng Loh; Cheng-Yen Lin; Feng-Yen Lin; Chien-Sung Tsai
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

6.  Inflammation and cardiopulmonary bypass.

Authors:  J H Levy; A B Kelly
Journal:  Can J Anaesth       Date:  1993-11       Impact factor: 5.063

7.  Effect of lornoxicam in lung inflammatory response syndrome after operations for cardiac surgery with cardiopulmonary bypass.

Authors:  Kosmas Tsakiridis; Paul Zarogoulidis; Giorgos Vretzkakis; Dimitris Mikroulis; Andreas Mpakas; Georgios Kesisis; Stamatis Arikas; Alexandros Kolettas; Giorgios Moschos; Nikolaos Katsikogiannis; Nikolaos Machairiotis; Theodora Tsiouda; Stavros Siminelakis; Thomas Beleveslis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

8.  Methylprednisolone inhibits increase of interleukin 8 and 6 during open heart surgery.

Authors:  T Kawamura; K Inada; H Okada; K Okada; R Wakusawa
Journal:  Can J Anaesth       Date:  1995-05       Impact factor: 5.063

Review 9.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

10.  Macrophage migration inhibitory factor in pediatric patients undergoing surgery for congenital heart repair.

Authors:  Sanah Merchant; Sumekala Nadaraj; Devyani Chowdhury; Vincent A Parnell; Cristina Sison; Edmund J Miller; Kaie Ojamaa
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.